US equities
|
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Psilera Inc/
Recent news which mentions Psilera Inc/
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
August 16, 2023
Tickers
CYBN
Tags
Psychedelics
Psychedelic/Assisted Therapies
Patents
From
Benzinga
Psilera's New Psychedelic Compounds: A Non-Hallucinogenic Promise For Depression And Neurodegenerative Disorders?
August 11, 2022
Tags
Dr/ Jackie von Salm
Market News
Markets
From
Benzinga
National Institute On Drug Abuse To Research Ayahuasca's Active Ingredient DMT In Partnership With Psilera Inc.
August 26, 2021
Tags
Benzinga
Psilera Inc/
psychedelics
From
Benzinga